Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Is A Disappointment In Store For Nu Skin (NUS) Q2 Earnings?

Published 08/04/2019, 09:03 PM
Updated 07/09/2023, 06:31 AM

Nu Skin Enterprises, Inc. (NYSE:NUS) is scheduled to release second-quarter 2019 results on Aug 6. This cosmetics company’s earnings outperformed the Zacks Consensus Estimate by average of 7.1% in the trailing four quarters.

Nu Skin Enterprises, Inc. Price and EPS Surprise



Nu Skin Enterprises, Inc. price-eps-surprise | Nu Skin Enterprises, Inc. Quote

Let’s see what’s in store for the company this time around.

What to Expect?

The Zacks Consensus Estimate for second-quarter earnings, which has moved down in the past 30 days to 83 cents, suggests a 23.1% decline from the year-ago figure. The consensus mark for revenues is $633 million, implying a decline of 10.1% from the year-ago quarter’s reported figure.

Factors to Note

The 100-day government campaign in Mainland China to inspect offerings of direct selling industries and health products is likely to have adversely impacted Nu Skin’s performance in the second quarter. Constant media scrutiny and limitations on sales meetings have also hurt consumers’ sentiment, which in turn is likely to hurt the company’s performance. Moreover, adverse currency fluctuations have possibly been a threat.

Nevertheless, the company’s efforts to strengthen the customer base and network of sales leaders are likely to drive revenues. Nu Skin’s focus on its three key pillars — Products, Programs and Platform — also bodes well.

Management expects revenues for the second quarter to be $622-$623 million compared with $704 million recorded in the year-ago period. Earnings are envisioned to be 82-84 cents per share.

What the Zacks Model Unveils

Our proven model doesn’t show a beat for Nu Skin this earnings season. For this to happen, a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Nu Skin has an Earnings ESP of 0.00% and a Zacks Rank #5 (Strong Sell). We caution against sell-rated stocks going into the earnings announcement.

Stocks Poised to Beat Earnings Estimates

Estee Lauder (NYSE:EL) has an Earnings ESP of +2.46% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.

General Mills (NYSE:GIS) has an Earnings ESP of +0.87% and a Zacks Rank #2.

Kraft Heinz (NASDAQ:KHC) has an Earnings ESP of +8.00% and a Zacks Rank #3.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Nu Skin Enterprises, Inc. (NUS): Free Stock Analysis Report

The Kraft Heinz Company (KHC): Free Stock Analysis Report

General Mills, Inc. (GIS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.